Literature DB >> 29436465

Impact of a pharmacy team-led intervention program on the readmission rate of elderly patients with heart failure.

Pamela M Moye1,2, Pui Shan Chu3, Teresa Pounds2, Maria Miller Thurston4,5.   

Abstract

PURPOSE: The results of a study to determine whether pharmacy team-led postdischarge intervention can reduce the rate of 30-day hospital readmissions in older patients with heart failure (HF) are reported.
METHODS: A retrospective chart review was performed to identify patients 60 years of age or older who were admitted to an academic medical center with a primary diagnosis of HF during the period March 2013-June 2014 and received standard postdischarge follow-up care provided by physicians, nurses, and case managers. The rate of 30-day readmissions in that historical control group was compared with the readmission rate in a group of older patients with HF who were admitted to the hospital during a 15-month intervention period (July 2014-October 2015); in addition to usual postdischarge care, these patients received medication reconciliation and counseling from a team of pharmacists, pharmacy residents, and pharmacy students.
RESULTS: Twelve of 97 patients in the intervention group (12%) and 20 of 80 patients in the control group (25%) were readmitted to the hospital within 30 days of discharge (p = 0.03); 11 patients in the control group (55%) and 7 patients in the intervention group (58%) had HF-related readmissions (p = 0.85).
CONCLUSION: In a population of older patients with HF, the rate of 30-day all-cause readmissions in a group of patients targeted for a pharmacy team-led postdischarge intervention was significantly lower than the all-cause readmission rate in a historical control group.
Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  elderly; heart failure; hospital; intervention; pharmacy; readmission

Mesh:

Year:  2018        PMID: 29436465     DOI: 10.2146/ajhp170256

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

Review 1.  The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.

Authors:  Lucianne M West; J Bradley Williams; Kathleen D Faulkenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10

Review 2.  Transitional Care Interventions for Patients with Heart Failure: An Integrative Review.

Authors:  Hai Mai Ba; Youn-Jung Son; Kyounghoon Lee; Bo-Hwan Kim
Journal:  Int J Environ Res Public Health       Date:  2020-04-23       Impact factor: 3.390

3.  An inpatient multidisciplinary educational approach to reduce 30-day heart failure readmissions.

Authors:  Ahmed Aljabri
Journal:  Saudi Pharm J       Date:  2021-03-25       Impact factor: 4.330

Review 4.  Medication Supports at Transitions Between Hospital and Other Care Settings: A Rapid Scoping Review.

Authors:  Shawn Varghese; Shoshana Hahn-Goldberg; ZhiDi Deng; Glyneva Bradley-Ridout; Sara J T Guilcher; Lianne Jeffs; Craig Madho; Karen Okrainec; Zahava R S Rosenberg-Yunger; Lisa M McCarthy
Journal:  Patient Prefer Adherence       Date:  2022-02-25       Impact factor: 2.711

5.  Development and validation of the Tool for Pharmacists to Predict 30-day hospital readmission in patients with Heart Failure (ToPP-HF).

Authors:  Melissa R Riester; Laura McAuliffe; Christine Collins; Andrew R Zullo
Journal:  Am J Health Syst Pharm       Date:  2021-09-07       Impact factor: 2.980

6.  Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure.

Authors:  DeAngelo McKinley; Pamela Moye-Dickerson; Shondria Davis; Ayman Akil
Journal:  Am J Mens Health       Date:  2018-11-28

7.  Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge.

Authors:  Letitia N Warunek; Nicole E Cieri-Hutcherson; Brian P Kersten; Amany K Hassan
Journal:  Pharmacy (Basel)       Date:  2021-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.